Pfizer, BioNTech seek first vaccine approval in U.S.

Pfizer, BioNTech seek first vaccine approval in U.S.

Washington – U.S. biotech giant Pfizer and German partner BioNTech sought approval Friday to roll out their coronavirus vaccine early, a first step toward relief as surging infections prompt a return to shutdowns that traumatized nations and the global economy earlier this year.

The world is looking to scientists for salvation from the global pandemic, as a new wave of infections forces New York to shut schools and California to implement night time curfews.

The U.S. Food and Drug Administration (FDA) said its vaccines committee would meet on Dec. 10 to discuss the request for emergency use authorization.

“The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines,” the organization’s head Stephen Hahn said in a statement.

“I want to assure the American people that the FDA’s process and evaluation of the data for a potential Covid-19 vaccine will be as open and transparent as possible.”

He said he could not predict how long the review would take but the federal government said ealrier the final green light would probably come in December.

“Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world,” Pfizer chief executive Albert Bourla said.

The BioNTech/Pfizer shot and another one being developed by the U.S. firm Moderna have taken the lead in the global chase for a vaccine.

EU Commission president Ursula von der Leyen said the European bloc could also approve both before the end of the year.…

Want to know more click here go to health news source.



Follow us get Health Tips Update
Close

Health Tips Language